Neuroscience

Stanford psychiatrist Mariella Suleiman explains the red flags, how it differs from postpartum depression, and why fast treatment matters.

A new brain activity score could help identify people at risk for cognitive decline, potentially opening a window for earlier intervention.

A new tool gives researchers spatially precise – and completely noninvasive – control over gene editing, with the potential to support more targeted treatments for neurological disease.

Wu Tsai Neurosciences Institute programs help Cardinal undergrads and community college students gain hands-on lab experience while exploring research careers.

Why ALS damages some nerve cells that control muscle movement but spares others remains unclear. Stanford Medicine’s Aaron Gitler and colleagues are searching for answers.

Karl Deisseroth helped pioneer optogenetics, now used in thousands of labs worldwide to study how nerve-cell activity shapes behavior.

A childhood fascination with electronics led Wu Tsai Neuro Faculty Scholar Paul Nuyujukian to study the brain from all kinds of angles – an approach he believes is essential to treating its disorders.

Scientists have viewed the brain as one organ for centuries. A Stanford Medicine-led discovery challenging that view could advance research into ALS, spinal muscular atrophy, and other neurological diseases.

The ability to study brain disorders that arise before birth has taken a leap forward as a Stanford Medicine team finds a new way to grow human brain tissue outside of the human brain.

The scanner pinpoints when and where brain activity occurs, opening new avenues for research on speech, memory, and neurological disorders.